Physician

Alexander Lafortune, M.D.

According to 2025 Medicare claims, Alexander Lafortune, M.D. (NPI: 1982047833) practices infectious disease in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bronx, NY. This provider's primary affiliated billing organization is PHYSICIAN AFFILIATE GROUP OF NEW YORK PC (NPI: 1013375526; TIN: 900603487) and primary practice location at 10451-5504. Lafortune is affiliated with the HHC ACO Inc (ACO ID: A1675), participating under the MSSP model.

Lafortune's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 24 traditional Medicare patients, billed 26 HCPCS/CPT codes, and received $2,582 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 3,625 prescription claims across 114 beneficiaries totaling $3,343,723 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $4,030 to $3,343,723. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.7K$7.4K2018 Medicare payment: $2,556 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,220 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $7,396 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,264 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,704 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,824 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,582 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20183041$2,556
20194283$4,220
202050114$7,396
20213055$4,264
20223858$4,704
20234056$4,824
20242426$2,582

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.3M$4.5M2015 Drug cost: $4,030 (USD; Tot_Drug_Cst)2016 Drug cost: $4,125 (USD; Tot_Drug_Cst)2017 Drug cost: $56,274 (USD; Tot_Drug_Cst)2018 Drug cost: $679,359 (USD; Tot_Drug_Cst)2019 Drug cost: $2,665,344 (USD; Tot_Drug_Cst)2020 Drug cost: $2,998,661 (USD; Tot_Drug_Cst)2021 Drug cost: $3,011,458 (USD; Tot_Drug_Cst)2022 Drug cost: $3,384,552 (USD; Tot_Drug_Cst)2023 Drug cost: $4,520,312 (USD; Tot_Drug_Cst)2024 Drug cost: $3,343,723 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201515132$4,030
20161277$4,125
2017N/R22$56,274
201869928$679,359
2019993,265$2,665,344
2020993,077$2,998,661
2021833,416$3,011,458
20221083,629$3,384,552
20231324,827$4,520,312
20241143,625$3,343,723

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes1111$116

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BiktarvyBictegrav/Emtricit/Tenofov Ala1805,520$690,830
OdefseyEmtricitab/Rilpiviri/Tenof Ala1344,140$477,414
TivicayDolutegravir Sodium1926,240$455,380
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf692,490$358,590
JulucaDolutegravir/Rilpivirine902,940$325,280

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Alexander Lafortune, M.D.?

Tedicare shows public-source Medicare data for Alexander Lafortune, M.D. (NPI 1982047833), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Lafortune, M.D. have ACO affiliation data?

Alexander Lafortune, M.D. is shown with ACO affiliation data for HHC ACO Inc (MSSP, ACO ID A1675).

What billing organization is linked to Alexander Lafortune, M.D.?

Alexander Lafortune, M.D. is linked to PHYSICIAN AFFILIATE GROUP OF NEW YORK PC (billing NPI 1013375526) in the available physician profile data.

Does Alexander Lafortune, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.